|
Name |
Chermesin C
|
Molecular Formula | C26H40O6 | |
IUPAC Name* |
methyl (3S,3'aR,4'S,4aS,5'S,6S,7S,8S,8aS)-3,6-dihydroxy-3'a,4,4,4',7,7',8a-heptamethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-4,5-dihydro-3H-1-benzofuran]-5'-carboxylate
|
|
SMILES |
C[C@H]1[C@H](C[C@@H]2[C@@]([C@]13C[C@@]4([C@H]([C@@H](C(=O)C(=C4O3)C)C(=O)OC)C)C)(CC[C@@H](C2(C)C)O)C)O
|
|
InChI |
InChI=1S/C26H40O6/c1-13-20(29)19(22(30)31-8)15(3)24(6)12-26(32-21(13)24)14(2)16(27)11-17-23(4,5)18(28)9-10-25(17,26)7/h14-19,27-28H,9-12H2,1-8H3/t14-,15-,16-,17-,18-,19-,24+,25-,26-/m0/s1
|
|
InChIKey |
HXWMOJBBTWPRRO-OQGCYAQCSA-N
|
|
Synonyms |
Chermesin C; CHEMBL4452130
|
|
CAS | NA | |
PubChem CID | 139048356 | |
ChEMBL ID | CHEMBL4452130 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 448.6 | ALogp: | 4.1 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 93.1 | Aromatic Rings: | 4 |
Heavy Atoms: | 32 | QED Weighted: | 0.458 |
Caco-2 Permeability: | -4.866 | MDCK Permeability: | 0.00002430 |
Pgp-inhibitor: | 1 | Pgp-substrate: | 0.821 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.855 |
30% Bioavailability (F30%): | 0.968 |
Blood-Brain-Barrier Penetration (BBB): | 0.632 | Plasma Protein Binding (PPB): | 42.95% |
Volume Distribution (VD): | 0.813 | Fu: | 42.01% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.812 |
CYP2C19-inhibitor: | 0.048 | CYP2C19-substrate: | 0.874 |
CYP2C9-inhibitor: | 0.033 | CYP2C9-substrate: | 0.025 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.064 |
CYP3A4-inhibitor: | 0.914 | CYP3A4-substrate: | 0.507 |
Clearance (CL): | 12.741 | Half-life (T1/2): | 0.102 |
hERG Blockers: | 0.078 | Human Hepatotoxicity (H-HT): | 0.334 |
Drug-inuced Liver Injury (DILI): | 0.1 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.935 | Maximum Recommended Daily Dose: | 0.931 |
Skin Sensitization: | 0.375 | Carcinogencity: | 0.725 |
Eye Corrosion: | 0.013 | Eye Irritation: | 0.019 |
Respiratory Toxicity: | 0.974 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003566 | 0.458 | D0W2EK | 0.299 | ||||
ENC006004 | 0.376 | D0Y2YP | 0.292 | ||||
ENC005403 | 0.370 | D0X7XG | 0.280 | ||||
ENC003849 | 0.364 | D0P0HT | 0.279 | ||||
ENC003565 | 0.357 | D04SFH | 0.277 | ||||
ENC003407 | 0.351 | D02JNM | 0.277 | ||||
ENC002099 | 0.349 | D0D2TN | 0.276 | ||||
ENC005965 | 0.338 | D0H2MO | 0.270 | ||||
ENC002941 | 0.337 | D0I2SD | 0.267 | ||||
ENC003552 | 0.336 | D08PIQ | 0.266 |